Volicure Trio 1mg/500mg/0.2mg Tablet
Marketer
HBC Lifesciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Volicure Trio 1mg/500mg/0.2mg Tablet
TriadGlyc 1 mg/500 mg/0.2 mg tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose. TriadGlyc should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar or feeling well; abrupt cessation can lead to elevated glucose, risking kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Regular meals and carrying a fast-acting glucose source are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals should seek medical advice. Regular blood glucose checks are necessary, along with potential blood tests to monitor blood cell counts and liver function.
Uses of Volicure Trio 1mg/500mg/0.2mg Tablet
Managing Type 2 diabetes
Major Benefits of Volicure Trio 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Volicure Trio 1 mg/500 mg/0.2 mg tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Volicure Trio 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Volicure Trio 1mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Volicure Trio 1 mg/500 mg/0.2 mg tablet whole; do not crush, chew, or divide it. Administer on an empty stomach.
How Volicure Trio 1mg/500mg/0.2mg Tablet works:
Each Volicure Trio tablet (1 mg/500 mg/0.2 mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Volicure Trio 1 mg/500 mg/0.2 mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Volicure Trio 1 mg/500 mg/0.2 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Volicure Trio 1 mg/500 mg/0.2 mg tablets is likely unsafe. Available evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Volicure Trio 1 mg/500 mg/0.2 mg tablets is likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is necessary. Furthermore, its use is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Volicure Trio 1 mg/500 mg/0.2 mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation at a low dose is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Volicure Trio 1mg/500mg/0.2mg Tablet :
Should you forget a Volicure Trio 1 mg/500 mg/0.2 mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Volicure Trio 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently